Highlights

August 28, 2012

Members of the ACCME Board of Directors and executive staff participated in a meeting of the Coalition for Physician Accountability held in August in Philadelphia. James F. Burke, MD, Vice-Chair, and Edward J. Susank, Treasurer, ACCME Board of Directors; and Murray Kopelow, MD, ACCME President...

August 28, 2012

The ACCME participated in the Association of Regulatory Boards of Optometry (ARBO) 2012 Annual Meeting, held in June in Chicago. Murray Kopelow, MD, ACCME President and Chief Executive, gave a presentation about the ACCME accreditation system. His participation...

August 28, 2012

The ACCME participated in the following meetings during the past few months as part of its ongoing collaboration with member organizations. Through joint leadership initiatives, the ACCME and member organizations...

August 28, 2012

On July 9, the US Food and Drug Administration (FDA) released its Risk Evaluation and Mitigation Strategy or REMS for extended-release and long-acting (ER/LA) opioid analgesics.

August 28, 2012

On July 26, 2012, the ACCME Board of Directors convened conversations with leadership from the recognized state/territory medical society CME accreditation system to discuss the challenges and opportunities facing accredited CME. The Board asked participants about the value their accreditation...

August 28, 2012

The Accreditation Council for CME has released the executive summary of its Board of Directors meeting, held July 26-27, 2012, at its Chicago offices. The Board...